Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-01-04 @ 8:34 AM
Study NCT ID:
NCT00540293
Status:
COMPLETED
Last Update Posted:
2021-03-12
First Post:
2007-10-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A2581157
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None